Green Thumb, Trulieve and other cannabis stocks up as much as 13% as details emerge on HHS recommendation to lower drug classification

Curaleaf, Cresco Labs and Verano also rally on details of recommendation by Department of Health and Human Services.

Previous post The Game Stop meme-stock frenzy — what can we learn?
Next post Trump and Biden both ‘threatening for the markets’, says Ray Dalio